Statement:
This article is limited to conducting research on the related industries and overseas markets, and does not make recommendations for any products or provide comments on any domestic policies.
The legality of the products mentioned in the article is only limited to overseas areas. Domestic readers are advised to take note and strictly comply with relevant laws and regulations of China.
This article does not constitute any investment or consumer advice.
This article is not suitable for minors to read.
On the morning of March 3rd, Eastern Time, two employees from the Washington News Center of 2FIRSTS interviewed Caesar, their marketing manager, at the APE exhibition. Caesar stated that the CBD market in the United States is expected to reach $20.4 billion by 2023.
During an interview with 2FIRSTS, Caesar revealed that APE has noticed a significant increase in sales of CBD products at recent exhibitions. He noted that compared to the tobacco industry and other related industries, the growth in CBD sales is much more substantial. It is projected that the CBD market in the United States will reach $20.4 billion by the year 2023, as stated by Caesar.
Caesar stated that the use of CBD is becoming increasingly widespread. Currently, many companies have started to incorporate CBD in food and drink products, such as butter, oil, or other grains.
Caesar announced that their next exhibition will be held in Medellin, South America. Over 90% of the exhibition spaces have already been sold. The exhibition in Dallas, USA, sold out 70% of its spaces within five months after the show.
Furthermore, Caesar told 2FIRSTS that APE was formerly known as the USA CBD Expo, but due to the growth of e-cigarettes, the USA CBD Expo had to add e-cigarette categories, thus evolving into the Alternative Products Expo.
Further reading:
The media company 2FIRSTS has been named the official partner of the APE Expo, a tobacco trade show in the United States. As a result, they will provide comprehensive coverage of the event.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
